Panel: Should Biologics Manufacturers Have to Disclose More About Their Patents?

Director Timothy “Tim” J. Shea, Jr. was quoted in the article “Panel: Should Biologics Manufacturers Have to Disclose More About Their Patents?,” published by The Center for Biosimilars. This article summarizes a panel at the 2021 Festival of Biologics USA conference about the biosimilars pathway in the Biologics Price Competition and Innovation Act (BPCIA).